Anthos Takes On Pharma Giants In Factor XI Anticoagulation Space

Start-Up Was First To Start A Phase III Trial

3d illustration red blood cells circulating in the blood vessels
Anthos's first Phase III trial aims to prevent blood clots in cancer patients • Source: Shutterstock

More from Cardiovascular

More from Therapeutic Category